These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 7771914

  • 41. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder.
    Bukstein OG, Kolko DJ.
    J Clin Child Psychol; 1998 Oct; 27(3):340-51. PubMed ID: 9789193
    [Abstract] [Full Text] [Related]

  • 42. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.
    Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K.
    Arch Gen Psychiatry; 1995 Jun; 52(6):434-43. PubMed ID: 7771913
    [Abstract] [Full Text] [Related]

  • 43. Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension.
    Ginsberg Y, Lindefors N.
    Br J Psychiatry; 2012 Jan; 200(1):68-73. PubMed ID: 22075648
    [Abstract] [Full Text] [Related]

  • 44. A double-blind, randomized, placebo/active controlled crossover evaluation of the efficacy and safety of Ritalin ® LA in children with attention-deficit/hyperactivity disorder in a laboratory classroom setting.
    Schulz E, Fleischhaker C, Hennighausen K, Heiser P, Oehler KU, Linder M, Haessler F, Huss M, Warnke A, Schmidt M, Schulte-Markworth M, Sieder C, Klatt J, Tracik F.
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):377-85. PubMed ID: 20973708
    [Abstract] [Full Text] [Related]

  • 45. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.
    Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G.
    Pediatrics; 2001 Oct; 108(4):883-92. PubMed ID: 11581440
    [Abstract] [Full Text] [Related]

  • 46. Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD.
    Steingard RJ, Goldberg M, Lee D, DeMaso DR.
    J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(3):394-9. PubMed ID: 8169185
    [Abstract] [Full Text] [Related]

  • 47. Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Weiss M, Hechtman L, Turgay A, Jain U, Quinn D, Ahmed TS, Yates T, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC.
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):675-88. PubMed ID: 17979587
    [Abstract] [Full Text] [Related]

  • 48. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies.
    Santos K, Palmini A, Radziuk AL, Rotert R, Bastos F, Booij L, Fernandes BS.
    Dev Med Child Neurol; 2013 Jul; 55(7):654-60. PubMed ID: 23480530
    [Abstract] [Full Text] [Related]

  • 49. Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD.
    Handen BL, Feldman HM, Lurier A, Murray PJ.
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):805-12. PubMed ID: 10405497
    [Abstract] [Full Text] [Related]

  • 50. Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder.
    Wigal SB, Childress A, Berry SA, Belden H, Walters F, Chappell P, Sherman N, Orazem J, Palumbo D.
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):690-699. PubMed ID: 28557548
    [Abstract] [Full Text] [Related]

  • 51. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Law SF, Schachar RJ.
    J Am Acad Child Adolesc Psychiatry; 1999 Aug; 38(8):944-51. PubMed ID: 10434485
    [Abstract] [Full Text] [Related]

  • 52. Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder.
    Scahill L, Bearss K, Sarhangian R, McDougle CJ, Arnold LE, Aman MG, McCracken JT, Tierney E, Gillespie S, Postorino V, Vitiello B.
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):125-131. PubMed ID: 27893955
    [Abstract] [Full Text] [Related]

  • 53. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD.
    Spencer TJ, Biederman J, Faraone S, Mick E, Coffey B, Geller D, Kagan J, Bearman SK, Wilens T.
    Am J Psychiatry; 2001 Apr; 158(4):611-7. PubMed ID: 11282697
    [Abstract] [Full Text] [Related]

  • 54. Effects of methylphenidate on reading in children with attention deficit disorder.
    Ballinger CT, Varley CK, Nolen PA.
    Am J Psychiatry; 1984 Dec; 141(12):1590-3. PubMed ID: 6507665
    [Abstract] [Full Text] [Related]

  • 55. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
    Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.
    Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
    [Abstract] [Full Text] [Related]

  • 56. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Medori R, Ramos-Quiroga JA, Casas M, Kooij JJ, Niemelä A, Trott GE, Lee E, Buitelaar JK.
    Biol Psychiatry; 2008 May 15; 63(10):981-9. PubMed ID: 18206857
    [Abstract] [Full Text] [Related]

  • 57. Prevalence and clinical correlates of tic disorders in a community sample of school-age children.
    Kraft JT, Dalsgaard S, Obel C, Thomsen PH, Henriksen TB, Scahill L.
    Eur Child Adolesc Psychiatry; 2012 Jan 15; 21(1):5-13. PubMed ID: 22038343
    [Abstract] [Full Text] [Related]

  • 58. Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
    Jafarinia M, Mohammadi MR, Modabbernia A, Ashrafi M, Khajavi D, Tabrizi M, Yadegari N, Akhondzadeh S.
    Hum Psychopharmacol; 2012 Jul 15; 27(4):411-8. PubMed ID: 22806822
    [Abstract] [Full Text] [Related]

  • 59. Efficacy of methylphenidate in patients with cerebral palsy and attention-deficit hyperactivity disorder (ADHD).
    Gross-Tsur V, Shalev RS, Badihi N, Manor O.
    J Child Neurol; 2002 Dec 15; 17(12):863-6. PubMed ID: 12593456
    [Abstract] [Full Text] [Related]

  • 60. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
    Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, Witwer AN, Swiezy NB, Cronin P, Shah B, Carroll DH, Young C, Wheeler C, McDougle CJ.
    Biol Psychiatry; 2007 Feb 15; 61(4):538-44. PubMed ID: 17276750
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.